COMP

(redirected from Cartilage oligomeric matrix protein)
Also found in: Medical, Wikipedia.
AcronymDefinition
COMPComplete
COMPComputer(s)
COMPCompare
COMPCompensation
COMPComponent
COMPComposition
COMPComprehensive
COMPCompetitive
COMPCompilation
COMPCompiled
COMPCompatibility
COMPCompound
COMPComposite
COMPCompiler
COMPComposer
COMPCompressor
COMPComplimentary (geometry)
COMPCompass
COMPComputational
COMPComplement
COMPCompartment
COMPCompensate
COMPComptroller
COMPComparator
COMPComp.os.ms-Windows.programmer (newsgroups, usenet)
COMPCoordinated Multipoint Transmission (telecommunications)
COMPCommittee for Orphan Medicinal Products (EMEA)
COMPCompression
COMPCompare Real and Pop
COMPCartilage Oligomeric Matrix Protein
COMPCollege of Osteopathic Medicine of the Pacific
COMPCanadian Organization of Medical Physicists
COMPCoronal Multi-Channel Polarimeter
COMPClever on Many Perspectives (rapper Jordan McElveen)
COMPCompressive Molding Planarization
COMPCompliance Monitoring Parameter
COMPCollege Outcomes Measure Program
COMPCollection Opportunity Management Plot
COMPChronic Otitis Media Purulenta (ear disease)
References in periodicals archive ?
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint.
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
1998) Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
2012) A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years.
8-fold higher concentrations of urinary deoxypyridinoline, serum RatLaps and serum cartilage oligomeric matrix protein than did control non-immunized mice (Fig.
We also found that inhibition of cathepsin K reduced cartilage degradation 11-25%, as measured by assays of cartilage oligomeric matrix protein in serum and deoxypyridinoline in urine.
Serum or plasma cartilage oligomeric matrix protein concentration as a diagnostic marker in pseudoachon-droplasia: Differential diagnosis of a family.
Major Finding: At 6 months after bariatric surgery, patients had a 20% drop from baseline BMI and their average serum level of procollagen type II N-terminal propeptide (PIIANP), a marker of cartilage synthesis, had risen 32%, while their average serum level of cartilage oligomeric matrix protein (COMP) had decreased by 36%.
Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family.
ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein.
Suggestion of nonlinear or phasic progression of knee ostearthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Full browser ?